Pentose phosphate pathway and ovarian steroidogenesis in rats following oxythiamine treatment.
D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology; D001205:Ascorbic Acid / Q000032:analysis; D002784:Cholesterol / Q000032:analysis; D005260:Female; D005954:Glucosephosphate Dehydrogenase / Q000032:analysis; D006913:Hydroxysteroid Dehydrogenases / Q000032:analysis; D009929:Organ Size; D010053:Ovary / Q000032:analysis / Q000033:anatomy & histology / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D010428:Pentosephosphates / Q000378:metabolism; D011743:Pyrimidines / Q000494:pharmacology; D051381:Rats; D013256:Steroids / Q000096:biosynthesis; D013385:Succinate Dehydrogenase / Q000032:analysis; D013844:Thiazoles / Q000494:pharmacology*; D014599:Uterus / Q000033:anatomy & histology
D000963:Antimetabolites; D010428:Pentosephosphates; D011743:Pyrimidines; D013256:Steroids; D013844:Thiazoles; D002784:Cholesterol; D006913:Hydroxysteroid Dehydrogenases; D005954:Glucosephosphate Dehydrogenase; D013385:Succinate Dehydrogenase; D001205:Ascorbic Acid